tiprankstipranks
Trending News
More News >
Emergent Biosolutions (EBS)
NYSE:EBS
US Market

Emergent Biosolutions (EBS) Cash flow

Compare
1,359 Followers

Emergent Biosolutions Cash Flow

EBS's free cash flow for Q3 2025 was $-5.70M. For the 2025 fiscal year, EBS's free cash flow was decreased by $293.70M and operating cash flow was $-2.30M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 58.70M$ -206.30M$ -34.10M$ 321.10M$ 536.90M
Investing Cash Flow
$ 125.20M$ 212.30M$ -381.30M$ -225.00M$ -151.90M
Financing Cash Flow
$ -190.00M$ -535.70M$ 481.20M$ -141.00M$ 69.50M
End Cash Position
$ 105.60M$ 111.70M$ 642.60M$ 576.30M$ 621.50M
Free Cash Flow
$ 35.80M$ -257.90M$ -149.90M$ 96.10M$ 395.00M
Currency in USD

Emergent Biosolutions Cash Flow